Author

A. A. Tobian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Nardin· 2 shared A. Pekosz· 2 shared B. Abel· 2 shared E. M. Bloch· 2 shared H. Kared· 2 shared M. Fehlings· 2 shared O. Laeyendecker· 2 shared A. Casadevall· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Nardin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 6, 2021

Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals

A. Redd, A. Nardin, H. Kared…·A. A. Tobian

The paper examines if CD8+ T-cell epitopes from 2020 SARS-CoV-2 convalescent individuals are mutated in the Omicron variant, finding only one epitope with a single amino acid change.

DOI 10.1101/2021.12.06.471446

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 8, 2020

CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entireSARS-CoV-2 proteome and show kinetics of early differentiation

H. Kared, A. D. Redd, E. M. Bloch…·T. C. Quinn

The paper identifies CD8+ T cell epitopes across the SARS-CoV-2 proteome in convalescent individuals and shows their differentiation kinetics and correlation with immune markers.

DOI 10.1101/2020.10.08.330688

humanflow cytometry

𝕏 PostBluesky

PathologybioRxivMay 13, 2020

A rapid, point of care red blood cell agglutination assay for detecting antibodies against SARS-CoV-2

R. L. Kruse, Y. Huang, H. Smetana…·Z. Z. Wang

This paper introduces a rapid, point-of-care red blood cell agglutination assay for detecting SARS-CoV-2 antibodies using a fusion protein that binds RBCs and displays the SARS-CoV-2 RBD.

DOI 10.1016/j.bbrc.2021.03.016

humanproteomics

𝕏 PostBluesky